Hong Jiang

Hong Jiang practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Hong Jiang's NPI, 1639326044, was assigned on August 27, 2008. Hong Jiang graduated from Zhejiang Medical University in 1988. Hong Jiang holds Florida license ME105446.

Hong Jiang's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Hong Jiang's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Hong Jiang to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Hong Jiang practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Hong Jiang's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Hong Jiang is board certified in neurology by the American Board of Psychiatry and Neurology. Hong Jiang is licensed in Florida.

Dmand AI lists glaucoma, shingles, vision problems and visual impairment and blindness among the conditions Hong Jiang treats.

CMS data shows 8,072 Medicare services from Hong Jiang across 8 procedure codes in 2024, for 187 Medicare patients. Medicare paid $63,094 for them.

CMS counts 187 Medicare patients who saw Hong Jiang in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Hong Jiang's median patient age at 65, with 70% women.

In 2024, Hong Jiang wrote 524 Medicare Part D claims for 128 patients. 75% of them were for generic drugs. CMS names the drug for 362 of them, across 9 drugs with 11 or more claims each, at $122,861 in total drug cost. In 2023, CMS named 313 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Hong Jiang for performance year 2024, reported as part of a group. Hong Jiang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Hong Jiang as offering telehealth.

Dmand AI links 382 papers to Hong Jiang, published from 2003 to 2025. 2020 was the busiest year, with 32. The most frequent topics are China, Asian People and Tomography, Optical Coherence. Hong Jiang has published most often in Zhonghua Yi Xue Yi Chuan Xue Za Zhi. Hong Jiang's most frequent co-authors are Silvia R. Delgado, Byron L. Lam, MD and Frederick F. Lang, MD.

CMS Open Payments shows 8 general payments to Hong Jiang from 4 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Horizon Pharma plc paid the most, $224.

Dmand AI lists 1 award for Hong Jiang, most recently CMS Stage 1 EHR in 2013.

Hong Jiang graduated from Zhejiang Medical University in 1988.

Hong Jiang is in network with 11 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.